AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33142168 — intervention group
Group type: EXPERIMENTAL
Intervention: Both environments (25 °C and 37 °C)
Number of subjects: 21
Study 33023430 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 8
Study 33023430 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 8
Study 36352377 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes distress e‐learning
Number of subjects: 74
Study 36352377 — intervention group
Group type: COMPARATOR
Intervention: Diabetes distress chapter (active control)
Number of subjects: 74
Study 35560945 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sectional modified dissection approach
Number of subjects: 1
Study 35560945 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sectional dissection approach
Number of subjects: 1
Study 32040959 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc (300 mg twice daily for 72 weeks)
Number of subjects: 416
Study 32040959 — intervention group
Group type: COMPARATOR
Intervention: Placebo (standard c-ART)
Number of subjects: 416
Study 35443651 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) technique
Number of subjects: 48
Study 35443651 — intervention group
Group type: COMPARATOR
Intervention: Traditional manual therapy (Control)
Number of subjects: 48
Study 34645870 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 1002
Study 34645870 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 1002
Study 34645870 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk group
Number of subjects: 1002
Study 34645870 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-risk group
Number of subjects: 1002
Study 34645870 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group
Number of subjects: 1002
Study 32640131 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention administered by specially trained nurses
Number of subjects: 5441
Study 32640131 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (control)
Number of subjects: 5441
Study 34396874 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg 1 hour before surgery
Number of subjects: 102
Study 34396874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 33040772 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention focused on 'eating for the gut microbiota'
Number of subjects: 45
Study 33040772 — intervention group
Group type: COMPARATOR
Intervention: Control group (dietary advice from healthcare provider)
Number of subjects: 45
Study 35941536 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (group O)
Number of subjects: 555
Study 35941536 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone (group H)
Number of subjects: 555
Study 35941536 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil (group S)
Number of subjects: 555
Study 35941536 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 555
Study 33427559 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dietary phosphorus intake (100 mg)
Number of subjects: 34
Study 35766690 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillotomy
Number of subjects: 134
Study 35766690 — intervention group
Group type: COMPARATOR
Intervention: Tonsillectomy
Number of subjects: 134
Study 36183738 — intervention group
Group type: COMPARATOR
Intervention: Penicillamine
Number of subjects: 53
Study 36183738 — intervention group
Group type: EXPERIMENTAL
Intervention: TETA4
Number of subjects: 53
Study 33342317 — intervention group
Group type: COMPARATOR
Intervention: IPL
Number of subjects: 100
Study 33342317 — intervention group
Group type: EXPERIMENTAL
Intervention: IPL + MGX
Number of subjects: 100
Study 32584806 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional treatments (incisions, tourniquets, black-stones)
Number of subjects: 9924
Study 32584806 — intervention group
Group type: EXPERIMENTAL
Intervention: Consulting traditional healers
Number of subjects: 9924
Study 32584806 — intervention group
Group type: EXPERIMENTAL
Intervention: Antivenom use
Number of subjects: 9924
Study 32584806 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term disabilities
Number of subjects: 9924
Study 32584806 — intervention group
Group type: EXPERIMENTAL
Intervention: Snakebite incidence
Number of subjects: 9924
Study 32584806 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-fatality rate
Number of subjects: 9924
Study 32584806 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity signs
Number of subjects: 9924
Study 35200040 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban and clopidogrel
Number of subjects: 100
Study 35200040 — intervention group
Group type: COMPARATOR
Intervention: Warfarin, clopidogrel, and aspirin
Number of subjects: 100
Study 32179516 — intervention group
Group type: EXPERIMENTAL
Intervention: Evacetrapib
Number of subjects: 8236
Study 32179516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8236
Study 36307892 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) - 5 fractions of 8 Gy
Number of subjects: 174
Study 36307892 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 174
Study 33331206 — intervention group
Group type: EXPERIMENTAL
Intervention: SHR0534 at doses of 10, 25, 50, or 100 mg
Number of subjects: 51
Study 33331206 — intervention group
Group type: EXPERIMENTAL
Intervention: SHR0534 at 5 mg
Number of subjects: 51
Study 33331206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 33331206 — intervention group
Group type: EXPERIMENTAL
Intervention: SHR0534
Number of subjects: 51
Study 32428844 — intervention group
Group type: EXPERIMENTAL
Intervention: Vidofludimus calcium (IMU-838)
Number of subjects: 0
Study 35698162 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise swallowing training (SST) program, integrated with all swallowing organs movement, duration of 4 weeks.
Number of subjects: 0
Study 35698162 — intervention group
Group type: COMPARATOR
Intervention: Routine dysphagia care (Control group).
Number of subjects: 0
Study 35698162 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise swallowing training (SST) program.
Number of subjects: 0
Study 35798138 — intervention group
Group type: EXPERIMENTAL
Intervention: Cassia fistula syrup (CFS)
Number of subjects: 70
Study 35798138 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 70
Study 33766820 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal fentanyl (NF) administered by lay carers
Number of subjects: 0
Study 33766820 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal midazolam (BM) administered by lay carers
Number of subjects: 0
Study 33766820 — intervention group
Group type: COMPARATOR
Intervention: Standard breakthrough medication administered by healthcare professionals
Number of subjects: 0
Study 32310680 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% w/w ECa 233 gel
Number of subjects: 30
Study 32310680 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 30
Study 35984704 — intervention group
Group type: EXPERIMENTAL
Intervention: CT900 at a dose of 12 mg/m2 every 2 weeks (q2Wk)
Number of subjects: 109
Study 35984704 — intervention group
Group type: EXPERIMENTAL
Intervention: CT900 at a dose of 12 mg/m2/q2Wk
Number of subjects: 109
Study 34237156 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck Scale for Suicide Ideation (BSSI)
Number of subjects: 101
Study 34237156 — intervention group
Group type: EXPERIMENTAL
Intervention: Columbia‐Suicide Severity Rating Scale (C‐SSRS)
Number of subjects: 101
Study 34237156 — intervention group
Group type: EXPERIMENTAL
Intervention: suicide item of the Hamilton Rating Scale for Depression (HRSD)
Number of subjects: 101
Study 32482970 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine Extended Release (GXR) 1-7 mg/d
Number of subjects: 1084
Study 32482970 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine Extended Release (GXR) 1-4 mg/d
Number of subjects: 1084
Study 35044235 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.7F stent
Number of subjects: 12
Study 35044235 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.0F stent
Number of subjects: 12
Study 35044235 — intervention group
Group type: COMPARATOR
Intervention: Control (no stent)
Number of subjects: 12
Study 32032231 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Squat Bar (TRAD)
Number of subjects: 32
Study 32032231 — intervention group
Group type: COMPARATOR
Intervention: Safety Squat Bar (SSB)
Number of subjects: 32
Study 32032231 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TRAD and SSB
Number of subjects: 32
Study 35244344 — intervention group
Group type: EXPERIMENTAL
Intervention: ephedrine + caffeine (EC)
Number of subjects: 142
Study 35244344 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 142
Study 32618522 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscope
Number of subjects: 72
Study 32618522 — intervention group
Group type: COMPARATOR
Intervention: Microscope
Number of subjects: 72
Study 37897465 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophagus deviation device + luminal esophageal temperature (LET) monitoring
Number of subjects: 120
Study 37897465 — intervention group
Group type: COMPARATOR
Intervention: Luminal esophageal temperature (LET) monitoring alone
Number of subjects: 120
Study 37897465 — intervention group
Group type: COMPARATOR
Intervention: Control group (LET monitoring)
Number of subjects: 120
Study 33506643 — intervention group
Group type: COMPARATOR
Intervention: CHADS2 score
Number of subjects: 2202
Study 33506643 — intervention group
Group type: COMPARATOR
Intervention: R2CHADS2 score
Number of subjects: 2202
Study 33506643 — intervention group
Group type: COMPARATOR
Intervention: CHA2DS2-VASc score
Number of subjects: 2202
Study 32728820 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (EX, n=20)
Number of subjects: 39
Study 32728820 — intervention group
Group type: COMPARATOR
Intervention: Control group (CTRL, n=19)
Number of subjects: 39
Study 33487060 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior locking plate
Number of subjects: 159
Study 33487060 — intervention group
Group type: COMPARATOR
Intervention: Closed reduction and cast immobilization (Control)
Number of subjects: 159
Study 32925571 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced support (follow-up with a trained peer supporter)
Number of subjects: 50
Study 32925571 — intervention group
Group type: COMPARATOR
Intervention: Routine support (no further follow-up)
Number of subjects: 50
Study 32993779 — intervention group
Group type: EXPERIMENTAL
Intervention: General health education
Number of subjects: 3788
Study 32993779 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised health education
Number of subjects: 3788
Study 35485464 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinous process stabilization using the microplate/screw system
Number of subjects: 360
Study 32520816 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Psychology and Neuroscience (PPN) intervention
Number of subjects: 104
Study 32520816 — intervention group
Group type: COMPARATOR
Intervention: Matched, active education control condition
Number of subjects: 104
Study 35441440 — intervention group
Group type: EXPERIMENTAL
Intervention: Tregs + rituximab
Number of subjects: 36
Study 35441440 — intervention group
Group type: EXPERIMENTAL
Intervention: Tregs only
Number of subjects: 36
Study 35441440 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 33356676 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% O2
Number of subjects: 60
Study 33356676 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% O2
Number of subjects: 60
Study 33356676 — intervention group
Group type: COMPARATOR
Intervention: 30% O2
Number of subjects: 60
Study 32789935 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) adjunctive to conventional therapy, 30 sessions, twice daily over 3 weeks (group A)
Number of subjects: 81
Study 32789935 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) adjunctive to conventional therapy, 30 sessions, once daily over 6 weeks (group B)
Number of subjects: 81
Study 32789935 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy without HBOT (group C)
Number of subjects: 81
Study 35571272 — intervention group
Group type: EXPERIMENTAL
Intervention: Seed storage time
Number of subjects: 31
Study 35571272 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative and quantitative traits
Number of subjects: 31
Study 35571272 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of variance
Number of subjects: 31
Study 35571272 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic advance, heritability, and genotypic coefficient of variation
Number of subjects: 31
Study 35571272 — intervention group
Group type: EXPERIMENTAL
Intervention: Identified high yielding varieties
Number of subjects: 31
Study 35571272 — intervention group
Group type: EXPERIMENTAL
Intervention: Clustering analysis
Number of subjects: 31
Study 34266435 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycopene
Number of subjects: 20
Study 34266435 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids (Prednisolone)
Number of subjects: 20
Study 33126918 — intervention group
Group type: EXPERIMENTAL
Intervention: Stuck-moving needle acupuncture
Number of subjects: 108
Study 33126918 — intervention group
Group type: COMPARATOR
Intervention: Common acupuncture
Number of subjects: 108
Study 33126918 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise
Number of subjects: 108
Study 34974818 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise (ECC)
Number of subjects: 17
Study 34974818 — intervention group
Group type: COMPARATOR
Intervention: Concentric exercise (CON)
Number of subjects: 17
Study 33915011 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge care bundle including medication reconciliation, counselling session and documentation transfer to primary care physician (PCP)
Number of subjects: 120
Study 33915011 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 120
Study 32344491 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 0
Study 32344491 — intervention group
Group type: EXPERIMENTAL
Intervention: Short sleep duration
Number of subjects: 0
Study 32344491 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequently insomnia
Number of subjects: 0
Study 32344491 — intervention group
Group type: COMPARATOR
Intervention: Long sleep duration
Number of subjects: 0
Study 32344491 — intervention group
Group type: COMPARATOR
Intervention: Morningness
Number of subjects: 0
Study 35883044 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained cord circulation And Ventilation (SAVE-method)
Number of subjects: 0
Study 35883044 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation outcomes from electronic surveys
Number of subjects: 0
Study 33495363 — intervention group
Group type: EXPERIMENTAL
Intervention: ATRA-ATO
Number of subjects: 855
Study 33495363 — intervention group
Group type: COMPARATOR
Intervention: ATRA-anthracycline
Number of subjects: 855
Study 36007937 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management aimed at reducing systolic BP to <120 mm Hg
Number of subjects: 9329
Study 34229972 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic drainage (using either lumen apposing metal stents (LAMS) or plastic stents tailored to the amount of necrotic debris)
Number of subjects: 40
Study 34229972 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic drainage
Number of subjects: 40
Study 34229972 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic drainage
Number of subjects: 40
Study 34229972 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 36461019 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention through CCD group sessions (5 educational group sessions, each lasting 45 minutes)
Number of subjects: 181
Study 36461019 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 181
Study 32545440 — intervention group
Group type: EXPERIMENTAL
Intervention: Endomeatal approach (EMA)
Number of subjects: 202
Study 32545440 — intervention group
Group type: COMPARATOR
Intervention: Posterior tympanotomy (PT)
Number of subjects: 202
Study 32545440 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 202
Study 33998345 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple interrupted (SI) suture pattern
Number of subjects: 0
Study 33998345 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple continuous (SC) suture pattern
Number of subjects: 0
Study 33998345 — intervention group
Group type: EXPERIMENTAL
Intervention: Cruciate (XT) suture pattern
Number of subjects: 0
Study 33998345 — intervention group
Group type: EXPERIMENTAL
Intervention: Unidirectional knotless continuous barbed suture (SF)
Number of subjects: 0
Study 33998345 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35462561 — intervention group
Group type: EXPERIMENTAL
Intervention: 23Na MRI
Number of subjects: 3
Study 35462561 — intervention group
Group type: EXPERIMENTAL
Intervention: 23Na MRI and DWI
Number of subjects: 3
Study 35462561 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 3
Study 35462561 — intervention group
Group type: COMPARATOR
Intervention: Inward Na+ conductance inhibitors (cariporide, eslicarbazepine acetate)
Number of subjects: 3
Study 32561928 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV retesting with DNA polymerase chain reaction (PCR) performed if initial tests are discrepant.
Number of subjects: 4451
Study 33013705 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss and exercise (WL + EX)
Number of subjects: 3
Study 33013705 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss (WL)
Number of subjects: 3
Study 33013705 — intervention group
Group type: COMPARATOR
Intervention: Health education control (HED)
Number of subjects: 3
Study 33971837 — intervention group
Group type: EXPERIMENTAL
Intervention: Full immunization status
Number of subjects: 482
Study 33971837 — intervention group
Group type: EXPERIMENTAL
Intervention: Geographic cluster of under immunization
Number of subjects: 482
Study 33971837 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal Tetanus Toxoid immunization status
Number of subjects: 482
Study 33971837 — intervention group
Group type: EXPERIMENTAL
Intervention: Place of delivery
Number of subjects: 482
Study 33971837 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific vaccines (Polio, BCG, DPT (1-3), Measles)
Number of subjects: 482
Study 36781490 — intervention group
Group type: EXPERIMENTAL
Intervention: VPZ 3 weeks
Number of subjects: 234
Study 36781490 — intervention group
Group type: COMPARATOR
Intervention: VPZ 8 weeks
Number of subjects: 234
Study 34427217 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold green laser (STL)
Number of subjects: 30
Study 34427217 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 30
Study 34059326 — intervention group
Group type: EXPERIMENTAL
Intervention: Transarterial radioembolization (TARE)
Number of subjects: 0
Study 34059326 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 0
Study 33046137 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted telomere lengths based on SNPs (rs11125529 and rs412658)
Number of subjects: 735
Study 33046137 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 735
Study 36001314 — intervention group
Group type: EXPERIMENTAL
Intervention: Omission of sentinel lymph node biopsy (SLNB)
Number of subjects: 29
Study 36001314 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions aimed at educating physicians, improving patient-physician communication, and facilitating preoperative multidisciplinary conversations
Number of subjects: 29
Study 32144493 — intervention group
Group type: EXPERIMENTAL
Intervention: Spot urinary sodium excretion (high: UNa+ > 50 or low: ≤ 50 mEq/L) at 2 h from furosemide administration
Number of subjects: 80
Study 35400072 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component implementation strategy
Number of subjects: 0
Study 35400072 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 33065643 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CRT) consisting of radiation (50.4 Gy) with cisplatin and 5-fluorouracil
Number of subjects: 99
Study 33065643 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (CT) consisting of 2 cycles of docetaxel plus cisplatin and 5-fluorouracil (DCF)
Number of subjects: 99
Study 33065643 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 99
Study 33065643 — intervention group
Group type: EXPERIMENTAL
Intervention: R0 resection rate
Number of subjects: 99
Study 33065643 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological nodal status
Number of subjects: 99
Study 32135413 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegbovigrastim (IMR) treatment (2.7 mL of Imrestor)
Number of subjects: 270
Study 32135413 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) treatment (2.7 mL of 0.9% saline)
Number of subjects: 270
Study 32135413 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegbovigrastim (IMR) treatment
Number of subjects: 270
Study 32135413 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) treatment
Number of subjects: 270
Study 33471429 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with conventional therapy (systemic antibiotics and trazodone)
Number of subjects: 13
Study 33471429 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy (laser/LEDs off) with conventional therapy (systemic antibiotics and trazodone)
Number of subjects: 13
Study 33471429 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 13
Study 33471429 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy (laser/LEDs off)
Number of subjects: 13
Study 35279934 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoting Resilience in Nurses (PRiN) programme
Number of subjects: 0
Study 35279934 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0